(Q34137758)

31 July 2017

1 reference

title

Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs (English)

1 reference

31 July 2017

0 references

1 reference

S Hernández-Díaz

1

1 reference

31 July 2017

L A García-Rodríguez

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

American Journal of Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

110 Suppl 3A

1 reference

31 July 2017

page(s)

20S-7S

1 reference

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND HOSPITAL ADMISSION FOR PERFORATED PEPTIC ULCER

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

A cohort study (with re-sampled comparator groups) to measure the association between new NSAID prescribing and upper gastrointestinal hemorrhage and perforation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Nonsteroidal antiinflammatory drugs, ulcers and risk: a collaborative meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

The role of non-steroidal anti-inflammatory drugs in acute liver injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

End-stage renal disease and non-narcotic analgesics: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

A Prospective Study of Drugs and Pregnancy: I. Psychopharmaca

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Maternal medications and environmental exposures as risk factors for gastroschisis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

First trimester maternal medication use in relation to gastroschisis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Exogenous hormones and other drug exposures of children with congenital heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Associations between drugs administered during pregnancy and congenital abnormalities of the fetus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Prescription drug use before and during pregnancy in a Medicaid population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Antirheumatic medication in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

NSAIDs: Maternal and Fetal Considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

The risks and benefits of taking aspirin during pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Differences in NSAID tolerability profiles. Fact or fiction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Oligohydramnios associated with prostaglandin synthetase inhibitors in preterm labour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Antenatal indomethacin--adverse fetal effects confirmed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

Nonsteroidal Antiinflammatory Drugs and Gastrointestinal Hospitalizations in Saskatchewan: A Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900682-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(00)00682-3

1 reference

release_vxpfooxlyvf4hdcbewk7l625xy

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vxpfooxlyvf4hdcbewk7l625xy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference